Tarsus Pharmaceuticals

Tarsus Pharmaceuticals is a clinical-stage pharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities, initially in ocular diseases with limited treatment alternatives. We are advancing our pipeline to address multiple diseases across various therapeutic categories, including eye care, dermatology, and other areas of unmet need.Tarsus Pharmaceuticals' flagship product, TP-03, has the potential to become the first FDA-approved treatment and standard of care for Demodex blepharitis.